Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cencora, Inc. Common Stock (NY:COR)

286.74 +2.30 (+0.81%)
Official Closing Price Updated: 7:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 Next >
Is Cash Flow a Problem for Walgreens Boots Alliance?
There are plenty of red flags surrounding the business. 
Via The Motley Fool
Peering Into Cencora's Recent Short Interest
Via Benzinga
Health Care Giant McKesson Dives Amid Big Revenue Miss
McKesson earnings beat estimates, but the drug and health supplies distribution giant badly missed sales estimates. MCK stock dived. 
Via Investor's Business Daily
Topics Earnings
Exposures Financial
Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years
Via Benzinga
COR Stock Earnings: Cencora Beats EPS, Beats Revenue for Q3 2024
COR stock results show that Cencora beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
Via Benzinga
A Closer Look at 4 Analyst Recommendations For Cencora
Via Benzinga
AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case
AbbVie petitions the U.S. Supreme Court to protect its corporate records, arguing a lower court ruling threatens attorney-client privilege. 
Via Benzinga
The 7 Most Undervalued Dividend Stocks to Buy in July 2024
For nearly 100 years income stocks have outperformed the market and these three undervalued dividend stocks are your best buys this month. 
Via InvestorPlace
3 Dividend Compounding Machines Poised for 30%+ Total Returns by 2026
Savvy investors consider three compounder stocks poised to deliver over 30% total returns and ensure steady income streams. 
Via InvestorPlace
(COR) - Analyzing Cencora's Short Interest
Via Benzinga
Drug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court
Cencora stock and other drug distributors fell on Wednesday, hit by Walgreens results, not the ruling that killed an opioid settlement. 
Via Investor's Business Daily
Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years
Via Benzinga
Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today
Via Benzinga
Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today
Via Benzinga
3 Undervalued Gems Set to Soar 1,000% by 2026
Discover the fundamentals behind three undervalued stocks to buy in the oil and gas, advertising, and biotechnology industries. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Bulletproof Your Retirement: 3 Stocks That Will Stand the Test of Time
Protect and grow your assets with these stable, retirement-proof stocks, which will deliver earnings growth and shareholder returns. 
Via InvestorPlace
Lululemon Athletica Was Among The Worst-Performing Stocks Last Week (May 19-May 26, 2024): Are These 10 Large-Cap Stock Losers In Your Portfolio?
10 worst-performing large-cap stocks last week. National Grid, James Hardie, KE Holdings, JD.Com, XP, Nordson, BeiGene, Lululemon, Walgreens, and Li Auto. 
Via Benzinga
Unveiling 4 Analyst Insights On Cencora
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,700 Today
Via Benzinga
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnoses, and medications. 
Via Benzinga
Topics Data Breach
Exposures Information Security
COR Stock Earnings: Cencora Beats EPS, Misses Revenue for Q2 2024
COR stock results show that Cencora beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
3 High-Quality Stocks That Will Never Put You in the Red
These quality stocks have real staying power and the ability to generate consistent profits and growth over the long haul. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
$1000 Invested In Cencora 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Here's How Much $100 Invested In Cencora 10 Years Ago Would Be Worth Today
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.